Already, Eli Lilly and Co. has announced plans to build two manufacturing plants at the park that are expected to create up to 500 jobs, in addition to 1,500 temporary construction jobs.
Nov 25, 2022 | ibj.comIn January 2021, Eli Lilly acquired pharmaceutical rights from Aashi Kahei Pharma of its experimental drug in early-stage testing for managing chronic pain.
Nov 24, 2022 | openpr.comThe city in July annexed 1,396 acres for LEAP, which includes about 600 acres east of Interstate 65 where Eli Lilly and Co. plans to spend $2.1 billion to construct two manufacturing sites.
Nov 21, 2022 | insideindianabusiness.comIn June 2020, Eli Lilly and Co. launched what it called Racial Justice Commitment, pledging $25 million and 25,000 volunteer hours over five years.
Dec 2, 2022 | wishtv.comIn order to overcome these side-effects and be suitable for consumption by elderly patients, Sosei Heptares and Eli Lilly have joined forces to investigate an alternative therapy.
Jan 19, 2022 | diamond.ac.ukLilly, with the smaller butterfly wings, was second runner-up in the Butterflies Babe of the Year pageant.
Aug 7, 2020 | butterfliesbangkok.comLilly, with the smaller butterfly wings, was second runner-up in the Butterflies Babe of the Year pageant.
Dec 2, 2022 | butterfliesbangkok.comLilly has moved to Lismore, which has a large deaf community, and is looking to establish a successful business here.
Dec 10, 2022 | abc.net.auREDMOND, Wash., Dec. 15, 2022 /PRNewswire/ -- Prescryptive Health, a healthcare technology company on a mission to rewrite the script for the U.S. pharmaceutical market, today announced a partnership with Eli Lilly and Company on a new and first-to-market subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits.
Dec 15, 2022 | prnewswire.comIn 2020, Lilly announced a $470 million investment in North Carolina’s Research Triangle Park.
Sep 20, 2018 | europeanpharmaceuticalreview.comEli Lilly and Co. has entered a collaboration agreement with Sosei Heptares to develop small molecules that modulate G protein-coupled receptor (GPCR) targets in diabetes and metabolic diseases.
Dec 19, 2022 | contractpharma.comJapan's PeptiDream ( OTCPK:PPTDF ) signed a collaboration and licensing agreement with Eli Lilly ( NYSE: LLY ) to discover and develop novel peptide drug conjugates (PDCs).
Dec 27, 2022 | seekingalpha.comTwo months later, Eli Lilly and Co. announced plans to invest $2.1 billion in two new manufacturing sites to anchor the district, creating up to 500 permanent jobs and 1,500 temporary construction jobs.
Dec 30, 2022 | ibj.comIn March, Eli Lilly acquired its 415-acre site at The Grounds for nearly $50 million.
Dec 30, 2022 | bizjournals.com